Plain-English translation of NCT06288711 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to deliver prolonged exposure therapy—a proven treatment for trauma—to people who are also being treated for opioid use disorder. The study will compare three groups: people who receive their usual opioid treatment only, people who get usual treatment plus 12 weekly therapy sessions delivered by video, and people who get therapy plus small financial rewards for attending sessions. Researchers believe that delivering therapy this way might help more people actually complete their treatment.
Many people with opioid use disorder have experienced serious trauma and have trauma-related symptoms, but they often don't get treated for the trauma because therapy appointments are hard to attend or access. This trial is trying to solve that problem by making therapy easier to access through video calls and by testing whether small financial incentives help people stay engaged.
You likely qualify if…
You likely don't qualify if…
If you're selected, you'll be randomly assigned to one of three groups. All participants will continue their regular opioid treatment and complete assessments (interviews and questionnaires) at the start, monthly for 12 weeks, and again at 3 and 6 months after the study ends. Some participants will also receive 12 weekly therapy sessions delivered over a secure video platform, where you'll work with a trained therapist to process traumatic memories and learn coping skills. One group may also receive small financial incentives for completing each session.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
United States